LE WE PMID CA
Cardiovascular risk3970Kardiovaskulaeres Risikoprofil

Acetylsalicylic acid Aspirin

Acromegaly

Adipokine

Adiponectin

Aids

Aldosterone

Ankle arm index

Aorta and great vessels (Aneurysm)

Arterial hypertension (BASKET)

Asymmetric dimethylarginine

Atherosclerosis (BASKET)

Atherosclerosis (Carotids and Basilaris)

Atherosclerosis (peripheral vessels)

Autoimmunity

Cardioprotective agents

Cardiovascular risk

CD36 FAT fatty acid translocase

CNS (Stroke BASKET)

CRP

Cushing s syndrome

Cystatin C

Diabetes mellitus (Involvement heart and vessels)

Endocannabinoid

Endothelial dysfunction

Erectile dysfunction

ERS UFR (Pharmacology)

Exercise (Physiology)

Fatty acids (Omega3)

Foam cell

Gamma Glutamyltransferase

Ghrelin

Glucocorticoids

Heart (Atrial fibrillation)

Heart (Coronary heart disease BASKET)

Heart (Implanted cardioverter defibrillator)

Heart rate variability

Hemodialysis (BASKET)

Homer

Homocysteine

Interleukin6

Isoprostane

Ivabradine

JNK

Kidney (Chronic renal failure)

Leptin

Lipoprotein a

Lipoprotein associated phospholipase A2

Macrophages

Magnesium (Hypomagnesiemia)

Migraine

Myeloperoxidase

Neopterin

Nitric oxide NO

Obesity (BASKET)

Paradontosis

Periodontosis

Polycystic ovary syndrome

Porphyromonas gingivalis

Pregnancy associated plasma protein A

Prostate (Neoplasia)

Psoriasis

Puls wave analysis

Radiation damage and control

Rosuvastatin

Sitosterolemia

Sleep apnea (obstructive)

Sleep disorder

Sodium (Salt)

Statin

Streptococcus mutans

Sudden death (cardiogenic)

Sympathetic nervous system

Testosterone

TGF beta

Tooth (Caries)

Transplantation

Type D personality

Uric acid (Hyperuricemia)

Vitamin D

2009  
1
Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.
[19432982] BMC Cardiovasc Disord 9(-): 17 (2009)
2007  
2
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
[18048761] Pharmacol Rev 59(4): 418-58 (2007)
2009  
3
Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
[19355805] Am J Manag Care 15(3 Suppl): S65-73 (2009)
2005  
4
Conditional risk factors for atherosclerosis.
[15704777] Mayo Clin Proc 80(2): 219-30 (2005)
2008  
5
Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
[18990318] Mayo Clin Proc 83(11): 1203-12 (2008)
2007  
6
Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
[17285783] Mayo Clin Proc 82(1): 29-39 (2007)
2009  
7
Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review.
[19884567] Hypertension 54(6): 1328-36 (2009)
2010  
8
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
[20479152] Circulation 121(21): 2284-93 (2010)
2009  
9
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
[19255343] Circulation 119(10): 1363-9 (2009)
2008  
10
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
[18833586] Circulation 118(14): 1497-1518 (2008)
2008  
11
Leptin and cardiovascular disease: response to therapeutic interventions.
[18574061] Circulation 117(25): 3238-49 (2008)
2009  
12
The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs.
[19901185] Circulation 120(21): 2033-5 (2009)
2011  
13
Chronic inflammation links cardiovascular, metabolic and renal diseases.
[22067929] Circ J 75(12): 2739-48 (2011)
2010  
14
Role of adiponectin in cardiovascular protection.
[20145339] Circ J 74(3): 432-3 (2010)
2009  
15
Obesity-related risk factors of cardiovascular disease.
[19940368] Circ J 73(12): 2204-5 (2009)
2009  
16
Adiponectin and cardiovascular disease.
[19261992] Circ J 73(4): 608-14 (2009)
2005  
17
Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
[15591226] Arterioscler Thromb Vasc Biol 25(2): 279-86 (2005)
2003  
18
Endothelial dysfunction: a marker of atherosclerotic risk.
[12588755] Arterioscler Thromb Vasc Biol 23(2): 168-75 (2003)
2008  
19
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
[18716322] Arterioscler Thromb Vasc Biol 28(9): 1582-3 (2008)
2005  
20
Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review.
[15879302] Arterioscler Thromb Vasc Biol 25(7): 1463-9 (2005)
2007  
21
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
[17726041] Eur Heart J 28(19): 2375-414 (2007)
2008  
22
New cardiovascular risk factors exist, but are they clinically useful?
[18276617] Eur Heart J 29(4): 441-4 (2008)
2008  
23
New cardiovascular risk determinants do exist and are clinically useful.
[18276616] Eur Heart J 29(4): 436-40 (2008)
2006  
24
Pregnancy-associated plasma protein-A and cardiovascular risk.
[16790470] Eur Heart J 27(14): 1637-9 (2006)
2010  
25
Where vascular meets neurodegenerative disease.
[20876491] Stroke 41(10 Suppl): S144-6 (2010)
2003  
26
Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.
[14576382] Stroke 34(11): 2741-8 (2003)
2003  
27
Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease.
[14593126] Stroke 34(11): 2583-90 (2003)
2010  
28
Advances in population-based studies.
[20075344] Stroke 41(2): e99-101 (2010)
2008  
29
Statin therapy for stroke prevention.
[18258828] Stroke 39(3): 1042-8 (2008)
2009  
30
A systematic review of angiotensin receptor blockers in preventing stroke.
[19892999] Stroke 40(12): 3876-8 (2009)
2009  
31
Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics.
[19324705] Philos Transact A Math Phys Eng Sci 367(1892): 1223-38 (2009)
2010  
32
Endocrine aspects of obstructive sleep apnea.
[20061419] J Clin Endocrinol Metab 95(2): 483-95 (2010)
2007  
33
Aldosterone as a cardiovascular risk hormone.
[17409575] Endocr J 54(3): 359-70 (2007)
2010  
34
Molecular determinants of the cardiometabolic phenotype.
[20384572] Endocr Metab Immune Disord Drug Targets 10(2): 109-23 (2010)
2007  
35
Glucocorticoids and cardiovascular disease.
[17984234] Eur J Endocrinol 157(5): 545-59 (2007)
2010  
36
Mortality in patients with pituitary disease.
[20086217] Endocr Rev 31(3): 301-42 (2010)
2010  
37
Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Porphyromonas gingivalis is the important role of intimal hyperplasia in the aorta.
[20501963] J Pharmacol Sci 113(2): 110-4 (2010)
2010  
38
Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Cell-surface structures of novel serotype k Streptococcus mutans strains and their correlation to virulence.
[20501965] J Pharmacol Sci 113(2): 120-5 (2010)
2010  
39
Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Implication of periodontal diseases in development of systemic diseases.
[20501966] J Pharmacol Sci 113(2): 103-9 (2010)
2010  
40
Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm.
[20501967] J Pharmacol Sci 113(2): 115-9 (2010)
2011  
41
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.
[22039429] PLoS One 6(10): e25920 (2011)
2007  
42
A two-carbon switch to sterol-induced autophagic death.
[17172803] Autophagy 3(1): 38-41 (2007)
2004  
43
Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.
[15229146] Clin Chem 50(7): 1113-5 (2004)
2009  
44
Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification.
[19395434] Clin Chem 55(6): 1056-7 (2009)
2009  
45
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
[19556446] Clin Chem 55(8): 1462-70 (2009)
2009  
46
Cystatin C and cardiovascular risk.
[19713275] Clin Chem 55(11): 1932-43 (2009)
2011  
47
Radiation as a risk factor for cardiovascular disease.
[21091078] Antioxid Redox Signal 15(7): 1945-56 (2011)
2003  
48
Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?
[14719473] Isr Med Assoc J 5(10): 736-8 (2003)
2008  
49
Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.
[17975198] Am J Respir Crit Care Med 177(4): 369-75 (2008)
2008  
50
Bacteremia originating in the oral cavity. A review.
[18521055] Med Oral Patol Oral Cir Bucal 13(6): E355-62 (2008)
2009  
51
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
[20032323] N Engl J Med 361(26): 2518-28 (2009)
2004  
52
Clinical usefulness of plasma homocysteine in vascular disease.
[15377241] Med J Aust 181(6): 314-8 (2004)
2011  
53
Preventing vascular disease - effective strategies for implementing guidelines in general practice.
[22003490] Aust Fam Physician 40(10): 825-8 (2011)
2009  
54
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
[19622820] JAMA 302(4): 412-23 (2009)
2007  
55
Erectile dysfunction: a marker of early coronary heart disease.
[17715608] Hellenic J Cardiol 48(4): 185-91 (2007)
2007  
56
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.
[18196656] Hellenic J Cardiol 48(6): 341-5 (2007)
2008  
57
Erectile dysfunction and coronary artery disease: a relationship for disclosure.
[18350775] Hellenic J Cardiol 49(1): 1-6 (2008)
2010  
58
Cardiovascular consequences of obstructive sleep apnoea.
[20308745] Indian J Med Res 131(-): 196-205 (2010)
2009  
59
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.
[19407053] Eur Respir J 33(5): 1195-205 (2009)
2007  
60
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
[17583180] Vasc Health Risk Manag 3(1): 99-108 (2007)
2008  
61
Measurement of endothelial function and its clinical utility for cardiovascular risk.
[18827914] Vasc Health Risk Manag 4(3): 647-52 (2008)
2009  
62
Periodontal bacteria and cardiovascular problems.
[19492958] Future Microbiol 4(5): 495-8 (2009)
2008  
63
Altered central catecholaminergic transmission and cardiovascular disease.
[18326552] Exp Physiol 93(6): 725-40 (2008)
2007  
64
Apo B/apo A-I ratio and cardiovascular risk prediction.
[17664987] Arq Bras Cardiol 88(6): e187-90 (2007)
2008  
65
Risk factors for the development of atherosclerosis in childhood and adolescence.
[18516390] Arq Bras Cardiol 90(4): 276-283 (2008)
2010  
66
Role of vitamin D in cardiovascular disease.
[20308705] Neth J Med 68(3): 113-8 (2010)
2012  
67
Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.
[21941583] Clin Dev Immunol 2012(-): 974648 (2012)
2009  
68
The dark side of testosterone deficiency: III. Cardiovascular disease.
[19342698] J Androl 30(5): 477-94 (2009)
2009  
69
Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence.
[19602651] Can Fam Physician 55(7): 691-6 (2009)
2009  
70
Vascular consequences of dietary salt intake.
[19339634] Am J Physiol Renal Physiol 297(2): F237-43 (2009)
2008  
71
Cardiovascular disease in transplant recipients: current and future treatment strategies.
[18309001] Clin J Am Soc Nephrol 3 Suppl 2(-): S29-37 (2008)
2008  
72
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
[18184879] Clin J Am Soc Nephrol 3(2): 505-21 (2008)
2011  
73
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.
[21472089] Clin Interv Aging 6(-): 27-35 (2011)
2008  
74
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.
[18686755] Clin Interv Aging 3(2): 341-9 (2008)
2009  
75
Vascular biomarkers in the metabolic syndrome.
[19379078] Expert Rev Mol Diagn 9(3): 209-15 (2009)
2009  
76
Endothelial dysfunction as a target for prevention of cardiovascular disease.
[19875572] Diabetes Care 32 Suppl 2(-): S314-21 (2009)
2010  
77
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
[20200624] Tex Heart Inst J 37(1): 25-39 (2010)
2008  
78
The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases.
[18408140] Exp Biol Med (Maywood) 233(6): 674-88 (2008)
2008  
79
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management.
[18402533] Expert Rev Cardiovasc Ther 6(4): 435-7 (2008)
2005  
80
Type D personality: the heart, stress, and cortisol.
[15820973] QJM 98(5): 323-9 (2005)
2008  
81
Adipokines--targeting a root cause of cardiometabolic risk.
[18550581] QJM 101(10): 767-76 (2008)
2010  
82
Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease.
[20948377] Curr Opin Nephrol Hypertens 19(6): 519-26 (2010)
2009  
83
Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.
[19374004] Curr Opin Nephrol Hypertens 18(3): 181-8 (2009)
2011  
84
Molecular mechanisms in exercise-induced cardioprotection.
[21403846] Cardiol Res Pract 2011(): 972807 (2011)
2009  
85
1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.
[19667238] Circulation 120(8): 687-98 (2009)
2008  
86
New techniques for assessing arterial stiffness.
[18358423] Diabetes Metab 34 Suppl 1(-): S21-6 (2008)
2010  
87
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
[20445552] J Invest Dermatol 130(7): 1785-96 (2010)
2009  
88
The endocannabinoid system: potential for reducing cardiometabolic risk.
[19373218] Obesity (Silver Spring) 17(10): 1821-9 (2009)
2011  
89
A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk.
[21445280] Ther Clin Risk Manag 7(-): 59-68 (2011)
2010  
90
Risk assessment for sudden cardiac death in dialysis patients.
[20959609] Circ Arrhythm Electrophysiol 3(5): 553-9 (2010)
2010  
91
Role of cardiovascular imaging in systemic autoimmune diseases.
[21160590] World J Cardiol 2(8): 237-42 (2010)
2011  
92
Increased heart rate and atherosclerosis: potential implications of ivabradine therapy.
[21526046] World J Cardiol 3(4): 101-4 (2011)
2008  
93
Childhood and adolescent obesity and adult mortality: a systematic review of cohort studies.
[18797731] Cad Saude Publica 24 Suppl 4(-): s558-68 (2008)
2006  
94
2010  
95
Magnesium in chronic kidney disease: challenges and opportunities.
[20090315] Blood Purif 29(3): 280-92 (2010)
2011  
96
Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward.
[21041983] J Atheroscler Thromb 18(3): 177-81 (2011)
2010  
97
Adipose tissue, inflammation and cardiovascular disease.
[20339797] Rev Assoc Med Bras 56(1): 116-21 (2010)
2011  
98
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
[21448299] Cancer Manag Res 3(-): 49-55 (2011)
2008  
99
The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.
[18199282] Int J Clin Pract 62(2): 338-51 (2008)
2009  
100
Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
[20111659] Rev Obstet Gynecol 2(4): 232-9 (2009)
2008  
101
Obesity: effects on cardiovascular disease and its diagnosis.
[18988724] J Am Board Fam Med 21(6): 562-8 (2008)
2010  
102
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
[21067804] Lancet 376(9753): 1670-81 (2010)
2010  
103
Microvascular responses to cardiovascular risk factors.
[20374483] Microcirculation 17(3): 192-205 (2010)
2010  
104
Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea.
[21112030] Best Pract Res Clin Endocrinol Metab 24(5): 843-51 (2010)
2010  
105
Role of sleep duration in the regulation of glucose metabolism and appetite.
[21112019] Best Pract Res Clin Endocrinol Metab 24(5): 687-702 (2010)
2010  
106
Obstructive sleep apnea: role in the risk and severity of diabetes.
[21112020] Best Pract Res Clin Endocrinol Metab 24(5): 703-15 (2010)
2010  
107
Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence.
[21112022] Best Pract Res Clin Endocrinol Metab 24(5): 731-43 (2010)
2006  
108
Evidence relating dietary sodium to cardiovascular disease.
[16772637] J Am Coll Nutr 25(3 Suppl): 256S-261S (2006)
2006  
109
Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival.
[16772636] J Am Coll Nutr 25(3 Suppl): 247S-255S (2006)
2006  
110
The influence of dietary sodium on blood pressure.
[16772635] J Am Coll Nutr 25(3 Suppl): 240S-246S (2006)
2006  
111
Dietary sodium intake and its relation to human health: a summary of the evidence.
[16766773] J Am Coll Nutr 25(3): 165-9 (2006)
2011  
112
Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
[21181310] Curr Atheroscler Rep 13(1): 51-6 (2011)
2010  
113
Early identification of cardiovascular risk using genomics and proteomics.
[20440292] Nat Rev Cardiol 7(6): 309-17 (2010)
2007  
114
The role of Homocysteine as a predictor for coronary heart disease.
[21289945] GMS Health Technol Assess 3(-): Doc11 (2007)
2010  
115
Potential role of uric Acid as a risk factor for cardiovascular disease.
[20195398] Korean J Intern Med 25(1): 18-20 (2010)
2009  
116
Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.
[18807180] Heart Fail Rev 14(3): 143-53 (2009)
2009  
117
OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.
[18758946] Heart Fail Rev 14(3): 155-64 (2009)
2008  
118
The use of high-sensitivity assays for C-reactive protein in clinical practice.
[18711404] Nat Clin Pract Cardiovasc Med 5(10): 621-35 (2008)
2011  
119
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
[21453547] Cardiovasc Diabetol 10(-): 25 (2011)
2007  
120
The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
[17681710] J Vasc Surg 46(3): 500-6 (2007)
2010  
121
Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
[20551373] Circ Cardiovasc Qual Outcomes 3(4): 406-12 (2010)
2011  
122
Epidemiologic review of long-term, low-level exposure to environmental chemicals and cardiovascular disease: an exposure-response relationship.
[21358127] Nihon Eiseigaku Zasshi 66(1): 13-21 (2011)
2010  
123
Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.
[20357497] Med Princ Pract 19(3): 167-75 (2010)
2004  
124
Interleukin-6 and cardiovascular diseases.
[15090695] Jpn Heart J 45(2): 183-93 (2004)
2009  
125
Migraine and cardiovascular disease: possible mechanisms of interaction.
[19470970] Neurology 72(21): 1864-71 (2009)
2004  
126
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.
[15184688] Psychosom Med 66(3): 305-15 (2004)
2007  
127
Peripheral blood gene expression profiling for cardiovascular disease assessment.
[18923935] Genomic Med 1(3-4): 105-12 (2007)
2010  
128
Metabolic and cardiovascular effects of ghrelin.
[20798901] Int J Pept 2010(-): - (2010)
2010  
129
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
[21098428] Circulation 122(25): e584-636 (2010)
2010  
130
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
[21098427] Circulation 122(25): 2748-64 (2010)
2010  
131
Cardiovascular disease and the role of oral bacteria.
[21523220] J Oral Microbiol 2(): (2010)
2010  
132
Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease.
[21523219] J Oral Microbiol 2(): (2010)
2010  
133
Effect of water hardness on cardiovascular mortality: an ecological time series approach.
[20031964] J Public Health (Oxf) 32(4): 479-87 (2010)
2010  
134
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
[20923854] Eur J Heart Fail 12(12): 1274-81 (2010)
PMC   
135
Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.
[24243630] J Clin Endocrinol Metab 99(1):E45-52 (2014)
PMC   
136
Body adiposity index and all-cause and cardiovascular disease mortality in men.
[23512375] Obesity (Silver Spring) 21(9):1870-6 (2013)
PMC   
137
Cocoa polyphenols and inflammatory markers of cardiovascular disease.
[24566441] Nutrients 6(2):844-80 (2014)
PMC   
138
Omega-3 index and cardiovascular health.
[24566438] Nutrients 6(2):799-814 (2014)
PMC   
139
C-reactive protein: clinical and epidemiological perspectives.
[24653858] Cardiol Res Pract 2014():605810 (2014)
PMC   
140
Toward new biomarkers of cardiometabolic diseases.
[23770128] Cell Metab 18(1):43-50 (2013)
PMC   
141
Genetic insights into cardiometabolic risk factors.
[24659834] Clin Biochem Rev 35(1):15-36 (2014)
PMC   
142
Therapy of obese patients with cardiovascular disease.
[23332347] Curr Opin Pharmacol 13(2):200-4 (2013)
PMC   
143
Genetic profiling for risk reduction in human cardiovascular disease.
[24705294] Genes (Basel) 5(1):214-34 (2014)
PMC   
144
The role of Notch pathway in cardiovascular diseases.
[24749110] Glob Cardiol Sci Pract 2013(4):364-71 (2013)
PMC   
145
Association between Serum Iron and the Severity of Coronary Artery Disease.
[24757630] Int Cardiovasc Res J 7(3):95-8 (2013)
PMC   
146
Association between single nucleotide polymorphism rs1044925 and the risk of coronary artery disease and ischemic stroke.
[24577316] Int J Mol Sci 15(3):3546-59 (2014)
PMC   
147
Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.
[24701475] J Clin Diagn Res 8(2):34-6 (2014)
PMC   
148
Slow yogic breathing through right and left nostril influences sympathovagal balance, heart rate variability, and cardiovascular risks in young adults.
[24741554] N Am J Med Sci 6(3):145-51 (2014)
PMC   
149
Neanderthal ancestry drives evolution of lipid catabolism in contemporary Europeans.
[24690587] Nat Commun 5():3584 (2014)
PMC   
150
Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.
[24082102] Proc Natl Acad Sci U S A 110(42):17023-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Kardiovaskulaeres Risikoprofil

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia